ReviewAnti-cancer agents in medicinal chemistry2026
Fish-Derived Antimicrobial Peptides (AMPs) as Anticancer Agents: A Mini-Review of
Review in Anti-cancer agents in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMarine fish provide a significant reservoir of Antimicrobial Peptides (AMPs) with potential anticancer properties, an area of growing scientific focus.
methodsThis review gathers findings from studies published between 2020 and 2024, sourced from databases such as Google Scholar, Scopus, BioMed Central, and ScienceDirect, identifying 15 relevant research papers highlighting the potential of fish-derived antimicrobial peptides in anticancer research.
resultsAMPs exhibit broad-spectrum anticancer activity against diverse cancer cell lines, primarily by inducing apoptosis or necrosis through mechanisms that involve ROS generation, mitochondrial dysfunction, and DNA damage. DISCUSSION: The therapeutic promise of fish AMPs is rooted in their diverse mechanisms, including highly selective cytotoxicity and the ability to exploit oxidative stress and trigger irreversible cell death, along with antiangiogenic properties. Future clinical development requires synthetic optimization and advanced drug delivery systems to enhance stability, bioavailability, and targeted delivery.
conclusionThis study highlights the promise of fish antimicrobial peptides as an additional class of anticancer therapies and explores future prospects, including improvements in drug administration and peptide modification, that might enhance their clinical application.
Indexed as
Identifiers
41787994What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.